Skip to main content
. 2016 Sep 7;15(2):139–154. doi: 10.1007/s40258-016-0277-7
Inclusion criteria
 Population Adults or children with chronic hepatitis B or C in whom assessment of liver fibrosis is indicated
 Intervention The Virtual Touch™ Quantification (VTq) software application used with the Siemens Virtual Touch™ Tissue Imaging systems (the Acuson S2000™ or S3000™ ultrasound platforms)
 Outcomes Correlation in assessment of stage of liver disease
Sensitivity and specificity (using AUROC) in assessment of liver fibrosis
Correlation in assessment of stage of fibrosis using Metavir score
Use of antiviral drugs
Quality-of-life measures
Hospital bed usage and length of stay
Requirement for liver biopsy
Device-related adverse events
 Study design Diagnostic accuracy studies
 Language restrictions English language only
Foreign language papers with English abstracts could be included
 Search dates 2009–current
Exclusion criteria
 Population Mixed patient cohort, use of a fibrosis score other than Metavir, overlapping cohorts with other identified populations
 Study design Case studies, editorials, letters, reviews
 Interventions No restriction

AUROC area under receiver operating characteristic